Metabolic Signatures of Extreme Longevity in Northern Italian Centenarians Reveal a Complex Remodeling of Lipids, Amino Acids, and Gut Microbiota Metabolism

The aging phenotype in humans has been thoroughly studied but a detailed metabolic profiling capable of shading light on the underpinning biological processes of longevity is still missing. Here using a combined metabonomics approach compromising holistic 1H-NMR profiling and targeted MS approaches, we report for the first time the metabolic phenotype of longevity in a well characterized human aging cohort compromising mostly female centenarians, elderly, and young individuals. With increasing age, targeted MS profiling of blood serum displayed a marked decrease in tryptophan concentration, while an unique alteration of specific glycerophospholipids and sphingolipids are seen in the longevity phenotype. We hypothesized that the overall lipidome changes specific to longevity putatively reflect centenarians' unique capacity to adapt/respond to the accumulating oxidative and chronic inflammatory conditions characteristic of their extreme aging phenotype. Our data in centenarians support promotion of cellular detoxification mechanisms through specific modulation of the arachidonic acid metabolic cascade as we underpinned increased concentration of 8,9-EpETrE, suggesting enhanced cytochrome P450 (CYP) enzyme activity. Such effective mechanism might result in the activation of an anti-oxidative response, as displayed by decreased circulating levels of 9-HODE and 9-oxoODE, markers of lipid peroxidation and oxidative products of linoleic acid. Lastly, we also revealed that the longevity process deeply affects the structure and composition of the human gut microbiota as shown by the increased extrection of phenylacetylglutamine (PAG) and p-cresol sulfate (PCS) in urine of centenarians. Together, our novel approach in this representative Italian longevity cohort support the hypothesis that a complex remodeling of lipid, amino acid metabolism, and of gut microbiota functionality are key regulatory processes marking exceptional longevity in humans.

[1]  M. Ciorba,et al.  Serum Analysis of Tryptophan Catabolism Pathway: Correlation With Crohn's Disease Activity , 2012, Inflammatory bowel diseases.

[2]  D. Willcox,et al.  Extending healthy ageing: nutrient sensitive pathway and centenarian population , 2012, Immunity & Ageing.

[3]  D. C. Cabelof,et al.  Down syndrome as a model of DNA polymerase beta haploinsufficiency and accelerated aging , 2012, Mechanisms of Ageing and Development.

[4]  J. Nicholson,et al.  Metabotyping of Long-Lived Mice using 1H NMR Spectroscopy , 2012, Journal of proteome research.

[5]  G. Kollias,et al.  Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(ΔARE/WT) mouse model. , 2011, Journal of proteome research.

[6]  S. Goto,et al.  Age-associated neurodegeneration and oxidative damage to lipids, proteins and DNA. , 2011, Molecular aspects of medicine.

[7]  N. Perkins,et al.  Adherence to a Mediterranean diet and plasma concentrations of lipid peroxidation in premenopausal women. , 2010, The American journal of clinical nutrition.

[8]  Marcus J. Claesson,et al.  Composition, variability, and temporal stability of the intestinal microbiota of the elderly , 2010, Proceedings of the National Academy of Sciences.

[9]  Z. D. Sharp,et al.  The role of mTOR signaling in controlling mammalian life span: what a fungicide teaches us about longevity. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  P. Brigidi,et al.  Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians , 2010, PloS one.

[11]  G. Burke,et al.  Association of Plasma Sphingomyelin Levels and Incident Coronary Heart Disease Events in an Adult Population: Multi-Ethnic Study of Atherosclerosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[12]  David M. Sabatini,et al.  An Emerging Role of mTOR in Lipid Biosynthesis , 2009, Current Biology.

[13]  John C Lindon,et al.  Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism , 2009, Proceedings of the National Academy of Sciences.

[14]  R. Weindruch,et al.  Metabolic shifts due to long-term caloric restriction revealed in nonhuman primates , 2009, Experimental Gerontology.

[15]  D. Chinkes,et al.  Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. , 2009, The Journal of clinical endocrinology and metabolism.

[16]  P. Calder.  Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. , 2008, Molecular nutrition & food research.

[17]  Haifeng Lu,et al.  Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.

[18]  C. Franceschi,et al.  The immune system in extreme longevity , 2008, Experimental Gerontology.

[19]  J. Doré,et al.  The inflammatory status of old age can be nurtured from the intestinal environment , 2008, Current opinion in clinical nutrition and metabolic care.

[20]  J. Han,et al.  A modular network model of aging , 2007, Molecular systems biology.

[21]  C. Franceschi.  Inflammaging as a major characteristic of old people: can it be prevented or cured? , 2007, Nutrition reviews.

[22]  Z. Ramadan,et al.  Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. , 2007, Journal of proteome research.

[23]  Martin Wiedmann,et al.  Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum , 2007, The ISME Journal.

[24]  C. Franceschi,et al.  Pathophysiology of ageing, longevity and age related diseases , 2007, Immunity & Ageing.

[25]  Elaine Holmes,et al.  Metabonomic investigations of aging and caloric restriction in a life-long dog study. , 2007, Journal of proteome research.

[26]  T. Finkel,et al.  TOR and aging: less is more. , 2007, Cell metabolism.

[27]  T. Teramoto,et al.  Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging. , 2007, Journal of atherosclerosis and thrombosis.

[28]  Ron A Wevers,et al.  Diagnosing inborn errors of lipid metabolism with proton nuclear magnetic resonance spectroscopy. , 2006, Clinical chemistry.

[29]  U. Wagner,et al.  The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS. , 2005, Clinical biochemistry.

[30]  P. Stenvinkel,et al.  Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. , 2005, The American journal of clinical nutrition.

[31]  N. Barzilai,et al.  Biological evidence for inheritance of exceptional longevity , 2005, Mechanisms of Ageing and Development.

[32]  D. Gauguier,et al.  Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. , 2005, Analytical chemistry.

[33]  C. Hsieh,et al.  Akt/PKB and p38 MAPK signaling, translational initiation and longevity in Snell dwarf mouse livers , 2004, Mechanisms of Ageing and Development.

[34]  M. Grootveld,et al.  Multicomponent analysis of encapsulated marine oil supplements using high-resolution 1H and 13C NMR techniques Published, JLR Papers in Press, September 1, 2003. DOI 10.1194/jlr.D300017-JLR200 , 2003, Journal of Lipid Research.

[35]  B. Weinert,et al.  Invited review: Theories of aging. , 2003, Journal of applied physiology.

[36]  O. Rådmark.  5-lipoxygenase-derived leukotrienes: mediators also of atherosclerotic inflammation. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[37]  C. Franceschi,et al.  Male/female ratio in centenarians: a possible role played by population genetic structure , 2002, Experimental Gerontology.

[38]  L. Kunkel,et al.  Life-long sustained mortality advantage of siblings of centenarians , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Fuchs,et al.  Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer , 2002, British Journal of Cancer.

[40]  H. Jeleń,et al.  Changes in the phospholipid composition of the arterial cell can result in severe atherosclerotic lesions. , 2001, The Journal of nutritional biochemistry.

[41]  N. Nagan,et al.  Plasmalogens: biosynthesis and functions. , 2001, Progress in lipid research.

[42]  W. Campbell.  New role for epoxyeicosatrienoic acids as anti-inflammatory mediators. , 2000, Trends in pharmacological sciences.

[43]  X. Chen,et al.  Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Yashin,et al.  Gene/longevity association studies at four autosomal loci (REN, THO, PARP, SOD2) , 1998, European Journal of Human Genetics.

[45]  W. Jira,et al.  Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. , 1997, Chemistry and physics of lipids.

[46]  G. Macfarlane,et al.  Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine , 1997, Microbial Ecology.

[47]  S. Pereira,et al.  Plasma arachidonic acid-rich phospholipids in Crohn's disease: response to treatment. , 1996, Clinical science.

[48]  E Magni,et al.  Mini‐Mental State Examination: a normative study in Italian elderly population , 1996, European journal of neurology.

[49]  M. Matsubara,et al.  15-Hydroxyeicosatetraenoic acid inhibits neutrophil migration across cytokine-activated endothelium. , 1994, The American journal of pathology.

[50]  E. Borden,et al.  Induction of Tryptophan Degradation In Vitro and In Vivo: A γ-Interferon-Stimulated Activity , 1986 .

[51]  S. Elsden,et al.  The end products of the metabolism of aromatic amino acids by clostridia , 1976, Archives of Microbiology.

[52]  G. Schmitz,et al.  Metabolism and atherogenic disease association of lysophosphatidylcholine. , 2010, Atherosclerosis.

[53]  G Castellani,et al.  Human models of aging and longevity. , 2008, Expert opinion on biological therapy.

[54]  E. Dennis,et al.  Detection and quantitation of eicosanoids via high performance liquid chromatography-electrospray ionization-mass spectrometry. , 2007, Methods in enzymology.

[55]  Luying Peng,et al.  Effects of Butyrate on Intestinal Barrier Function in a Caco-2 Cell Monolayer Model of Intestinal Barrier , 2007, Pediatric Research.

[56]  G. Gross,et al.  Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury. , 2007, Prostaglandins & other lipid mediators.

[57]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[58]  N. Aiyar,et al.  Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells , 2006, Molecular and Cellular Biochemistry.

[59]  W. Jira,et al.  Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients. , 1998, Chemistry and physics of lipids.

[60]  E. Borden,et al.  Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. , 1986, Journal of interferon research.